Rationale: Protein S-palmitoylation is the posttranslational attachment of a saturated 16-carbon palmitic acid to a cysteine side chain via a thioester bond. Palmitoylation can affect protein localization, trafficking, stability, and function. The extent and roles of palmitoylation in endothelial cell (EC) biology is not well-understood, partly because of technological limits on palmitoylprotein detection.
P rotein S-acylation is the attachment of a lipid to a cysteine residue in a protein via a thioester linkage. 1 Protein S-acylation is often called "palmitoylation" because the lipid is commonly (but not exclusively) the saturated 16-carbon palmitate; thus, "palmitoylation" is used in this report to denote protein S-acylation. Palmitoylated proteins typically are membrane-associated because of other lipid modifications (such as myristoylation or prenylation) or additional membrane-embedded domains. Palmitoylation can affect the trafficking, localization, stability, and function of a protein. 2 Unlike other lipid modifications, palmitoylation is reversible and likely regulated.
Two major developments over the past several years have dramatically changed the study of protein palmitoylation. The first has been the introduction of powerful new methods to detect palmitoylproteins. Classically, palmitoylation was detected primarily by metabolic labeling of proteins with tritiated palmitate followed by fluorography. This approach is time-consuming (requiring weeks to months for film exposures), insensitive, and requires advance knowledge of the palmitoylprotein. More recently, palmitoylproteins have been characterized using acyl-biotinyl exchange (ABE) [3] [4] [5] or metabolic labeling with palmitate analogs amenable to chemical derivatization with reporter groups, typically using coppercatalyzed cycloaddition ("click") chemistry. 6, 7 ABE involves first blocking free thiols on isolated proteins, followed by cleaving palmitoyl groups with the neutral base hydroxylamine (HA), and the derivatization of the newly formed thiols using reporter groups such as biotin (Supplemental Figure I ). ABE and "clickable" palmitate analogs 8, 9 are much more powerful techniques than tritiated palmitate because they are very sensitive and can be performed relatively rapidly. 10 Furthermore, unlike tritiated palmitate, neither approach necessarily requires advanced knowledge of the palmitoylprotein and both can be used to isolate total palmitoylproteins from cells or tissues. These approaches have been applied to the elucidation of all palmitoylproteins from a variety of sources, including yeast, 4 and several mammalian cell types. 3, 6, 7, [11] [12] [13] [14] The second development has been the discovery of the zinc finger DHHC domain-containing (ZDHHC) family of protein acyl transferases (PAT), [15] [16] [17] thus identifying the longsought enzymatic activity catalyzing protein palmitoylation. There are 23 ZDHHC family members in humans characterized by the presence of a highly conserved tetrapeptide repeat (Asp-His-His-Cys, or DHHC in single-letter code) that lies within a larger conserved cysteine-rich domain. ZDHHC proteins have multiple predicted transmembrane domains and have been found in multiple membrane compartments, including endoplasmic reticulum, Golgi, and plasma membrane. 18 ZDHHC family members are likely responsible for the palmitoylation of most palmitoylproteins, based on experiments in yeast showing that the palmitoylation of nearly all known palmitoylproteins could be attenuated by the deletion of one or more ZDHHC genes. 4 An increasing array of diseases in mice and humans has been associated with mutations in various ZDHHC family members. 19 -21 These data suggest that although there are multiple PAT paralogs, they likely are not functionally redundant and may serve critical independent functions in vivo. Many questions regarding the ZDHHC family of PATs remain unanswered, including the nature of their substrate specificity and regulation.
Protein palmitoylation has not been well-studied in the context of endothelial cells (ECs), the major cell type localized at the interface of blood and tissue representing the largest endocrine organ in the body. 22 Earlier work from our laboratory has shown that endothelial nitric oxide synthase (eNOS), an enzyme that produces the gaseous messenger nitric oxide, is palmitoylated at two cysteines in the amino terminus. 23 Palmitoylation of eNOS is important for trafficking to the plasmalemmal membrane domains, termed caveolae, and for its cellular activity. 24 eNOS can be palmitoylated by several Golgi-localized ZDHHC enzymes, and siRNA-mediated knockdown of one of these (ZDHHC21) leads to mislocalization of eNOS and impaired nitric oxide production. 25 Because the endothelium is critical for many aspects of vascular health and disease, we used ABE to globally isolate palmitoylproteins from ECs and to begin to search for novel substrates for ZDHHC proteins that regulate EC function. Here, we report the identification of Ͼ150 palmitoylprotein candidates, many of which have not been reported previously. In particular, we identify superoxide dismutase-1 (SOD1) as an unexpected palmitoylprotein. Mutation of C6 on SOD1 blocks palmitoylation and diminishes enzymatic activity and nuclear localization, thus supporting an important biological role for SOD1 palmitoylation. In addition, using ABE in combination with siRNA-mediated knockdown of two ZD-HHC paralogs enriched in EC, we show that palmitoylation of the adhesion protein platelet endothelial cell adhesion molecule-1 (PECAM1) is dependent on ZDHHC21. Knock-down of ZDHHC21 is shown to affect PECAM1 protein levels. Thus, the application of ABE-based palmitoylproteomics expands the scope of palmitoylation in endothelial cells and suggests that ZDHHC enzymes are likely potential targets for vascular diseases.
Methods

Cell Culture
Detailed Methods are provided in the Online Supplement. EA.hy 926, human umbilical vein endothelial cells, HEK 293T, and COS-7 cells were cultured using standard techniques. HEK 293T cells and COS-7 cells were transfected using either Fugene or Lipofectamine 2000 according to manufacturer's instructions.
ABE
ABE was performed based on a published protocol 5 with minor modifications. Confluent EA.hy 926 or human umbilical vein endothelial cell (passage Յ5) cells were lysed in 2 mL of lysis buffer (50 mmol/L Tris, 5 mmol/L EDTA, 150 mmol/L NaCl, 1.7% ␤-octyl glucoside or 1% NP-40, 10% glycerol, 5 mmol/L MgCl 2 , 4.5 mg/mL sodium pyrophosphate, 2.1 mg/mL NaF, 0.3 mg/mL AEBSF, 1 mmol/L NaVO 3 , 2 mg/mL complete protease inhibitor tablet; Roche; pH 7.4) per C150 plate. Extracted proteins (2-8 mg) were then precipitated using several volumes of ice-cold acetone. After resuspension, free thiols were then blocked by addition of 20 mmol/L methyl methanethiosulfonate (Fluka). After removal of excess methyl methanethiosulfonate via protein precipitation and resuspension, the solution was split in half. Both halves were treated with 1 mmol/L Biotin-HPDP (Thermo Scientific). Simultaneously, one half was treated with HA (NH 2 OH; pH 7.4, 1 mol/L final concentration) and the other was treated with Tris buffer pH 7.4 as a control. Biotinylated proteins were then captured on streptavidinconjugated resin (Sigma Aldrich), washed, and eluted with 1% ␤-mercaptoethanol.
Subsequently, the proteins were analyzed by Western blotting or by liquid chromatography mass spectrometry (MS)/MS. Raw liquid chromatography mass spectrometry (LC-MS)/MS spectra were assigned to proteins using Mascot software.
Western Blotting
SDS PAGE, electroblotting, and probing with primary and secondary antibodies were performed using standard techniques.
Immunofluorescence of SOD1
COS cells were grown on glass cover slips and transfected with HA-tagged SOD1. SOD1 was detected with anti-HA antibody (Roche 3F10) and goat antirat-488 (Invitrogen), and visualized using a Leica TCS SP5 spectral confocal microscope. Quantification was performed by a blinded independent judge. 
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Immunopurification of SOD1
SOD1 wild-type (WT) or C6S, labeled with an HA-affinity tag at the carboxyl terminus, was transfected in HEK-293T cells. SOD1 was immunoprecipitated from cell lysates using sepharose resin conjugated with anti-HA antibody (Sigma) overnight, and then eluted with 100 g/mL anti-HA peptide (Sigma) in wash buffer.
Tritiated Palmitate Incorporation
HEK 293 cells were transfected with WT eNOS, eNOS C15/C26S, WT SOD1, or SOD1 C6S and metabolically labeled with 3 H palmitate as described. 25 eNOS or SOD1 was immunopurified from lysates of transfected cells, and analyzed by scintillation counting.
Quantitative Reverse-Transcription Polymerase Chain Reaction
RNA isolation, reverse-transcription, and quantitative polymerase chain reactions were performed as described, 26 except that GAPDH was used for normalization of transcript abundance.
Reactive Oxygen Species Levels and SOD Activity
Reactive oxygen species generation was measured by the oxidation of 2,7-dichlorofluorescin diacetate (Molecular Probes). Transfected cells were incubated with dichlorofluorescin diacetate 5 mol/L for 30 minutes at 37°C, and subsequently analyzed by flow cytometry. Activity of purified SOD1 was determined using the SOD assay kit (Dojindo Molecular Technologies) as described by the manufacturer. Purified bovine SOD1 (Sigma) was used to determine a standard curve.
siRNA Knockdown
Knockdown of ZDHHC3 and ZDHHC21 in EA.hy 926 cells was performed as described, 25 except when scaled-up to accommodate larger tissue culture plates. Cells were harvested and analyzed 96 hours after transfection. All-star nonsilencing control siRNA (Qiagen) was used when indicated.
Statistics
The two-tailed Student t test was used to compare treated samples with controls. PϽ0.05 was considered to be significant.
Results
Proteomic Analysis of Palmitoylated Proteins in ECs
To appreciate the scope and significance of protein palmitoylation in ECs, we globally isolated total palmitoylproteins (in five different experiments) from EA.hy 926 cells (an immortalized human EC line) using ABE 5 and subsequently identified the proteins by mass spectrometry (Supplemental Figure I ). EA.hy 926 cells are a stable human EC line that retains many of the characteristics of primary ECs, including expression of EC surface proteins such as intercellular adhesion molecule, vascular cell adhesion molecule, PECAM, and factor VIII-related antigen, 27, 28 as well as expression of a similar array of miRNA, as those found in human umbilical vein endothelial cell. 29 All experiments were performed in the absence (Ϫ) or presence (ϩ) of HA to discriminate between proteins that do not or do have a labile thioester linkage between palmitate and the thiol. Proteins enriched in the absence of HA likely reflect a false-positive result.
After combining all the data, candidate palmitoylproteins were defined based on the mass spectrometry data (database searching performed using Mascot Distiller). Palmitoylproteins were defined as those for which the Mascot protein score was Ͼ56 in the ϩHA samples and the Mascot protein score was Ͻ56 in the ϪHA samples. In addition, we screened all the final proteins to ensure that none appeared to be among the proteins known to be false-positives by ABE, such as ubiquitin conjugating enzymes that use lipoic acid or phosphopantetheine cofactors, or enzymes that act on acyl-CoA substrates. 3 Using these criteria, Ͼ150 palmitoylproteins were classified and are shown in Supplemental Table I . Proteins that were identified but are likely to be either contaminants or falsepositives are shown in Supplemental Table II . A subset of the identified proteins was confirmed by ABE performed with and without HA, followed by semiquantitative Western blotting ( Figure 1A) . The recovery of the protein in the presence, but not the absence, of HA demonstrates that the protein is palmitoylated. As seen in Figure 1A , the known palmitoylproteins eNOS, PECAM1, calnexin, Yes, R-Ras, total Ras, and caveolin-1 and the novel palmitoylprotein SOD1 are enriched in the presence of HA treatment. Hsp90 and c-Src, which are not palmitoylated, were used as negative controls. Similary, ABE followed by Western blotting confirmed the presence of several palmitoyl proteins, including PECAM1 and SOD1, in primary cultures of human umbilical vein endothelial cells ( Figure 1B ).
Further analysis of the identified proteins was performed by ascertaining whether the protein was previously identified as palmitoylated by searching published palmitoylproteomes identified via mass spectrometry in other human cell types, 6, [11] [12] [13] 30 by searching for the key word "palmitate" in human protein entries in the Uniprot database (www.uniprot.org), and by performing semiautomated batch Pubmed searches (using the Web site pmid.us) for every identified palmitoylprotein in conjunction with the search terms "palmitoylation" or "palmitate" or "palmitoyl transferase." Of all proteins, nearly one-third (43 total) were not previously reported. We describe two examples of advances that have resulted from applying ABE and mass spectrometry technology to the study of ECs: (1) the identification of novel unanticipated palmitoylproteins, such as SOD1, and (2) the use of ABE to associate activity of individual PAT paralogs with substrate palmitoylproteins.
Identification of SOD1 as a Novel Palmitoylprotein
One protein with strong mass spectrometry evidence supporting its palmitoylation but that has not been described previously is SOD1. SOD1 has been intensively studied and is an important enzyme that protects cells from oxidative damage by converting superoxide anion into hydrogen peroxide. In addition, mutations in SOD1 are associated with the familial variant of amyotrophic lateral sclerosis, also known as Lou Gehrig disease. Examination of the mass spectrometry data revealed that eight different peptides mapping to SOD1 were detected with high Mascot scores (and expectation values Ͻ0.05) in the ϩHA samples, but not in the ϪHA-treated samples ( Figure 1C, D) . This was confirmed by Western blotting for SOD1 after ABE ( Figure 1A,  B ). Mutagenesis of C6 to serine (C6S) in SOD1 led to a loss of palmitoylation when expressed in HEK-293T cells ( Figure 1E) , as determined by ABE and Western blotting. In addition, the C6S mutant SOD1 displayed reduced incorporation of tritiated palmitate ( Figure 1F ), demonstrating that C6 is the likely site of palmitoylation in SOD1.
Next, we explored two possible functional consequences of S-acylation of SOD1. Because palmitoylation affects the subcellular localization of many proteins, we examined the distribution of WT and C6S SOD1 in transfected cells. SOD1 is mainly soluble and localizes in the cytosol as well as in peroxisomes, mitochondria, and nuclei. 31 Expression of WT SOD1 in COS cells resulted in predominate cytoplasmic and nuclear localization (co-labeled with the nuclear marker DAPI) in approximately 70% of the cells examined, whereas C6S SOD1 was frequently excluded from the nucleus ( Figure   2A ; quantified in Figure 2B ). These results suggest that C6 is involved in the nuclear targeting of SOD1.
We also examined whether palmitoylation affected the enzymatic activity of SOD1. Long-chain acylation previously has been reported to alter activity of certain mitochondrial enzymes. 32 Transfection of WT, but not C6S SOD1, into HEK293T cells reduced the levels of reactive oxygen species , the raw extraction ion spectrogram is shown to demonstrate the presence of the peptide only in samples treated with HA. E, Wild-type (WT) SOD1, heterologously expressed in HEK 293T cells, is palmitoylated, but the C6S mutant is not based on ABE followed by Western blot for SOD1. F, Incorporation of tritiated palmitate as measured by scintillation counting of heterologously expressed proteins after immunopurification. The SOD1 C6S mutant blocks incorporation of tritiated palmitate relative to WT. As a control, WT and palmitoylationdeficient C15S/C26S mutant of endothelial nitric oxide synthase (eNOS) is shown. Similar amounts of protein recovered by immunopurification are confirmed by Western blotting. The data are the mean of two independent experiments performed in triplicate.
as measured by fluorescence-activated cell sorting analysis of cells treated with the reactive oxygen species-sensitive dye dichlorofluorescin diacetate (Molecular Probes; Figure 2C , 2D). Expression levels of WT and C6S were similar, as judged by Western blotting (Figure 2E ), suggesting that the activity of the mutant protein is reduced relative to WT. To assess whether this reduction was attributable to changes in the specific activity of SOD1, we purified WT and C6S HA-tagged SOD1 proteins from HEK cells to nearhomogeneity using anti-HA resin ( Figure 2F ) and assayed enzymatic activity directly. C6S SOD1 displayed approximately 30% reduction in specific activity relative to the WT enzyme ( Figure 2G ). In sum, these data suggest that palmitoylation of SOD1 at C6 is important for the ability of SOD1 to localize to the nucleus and to optimally scavenge superoxide. It is not clear whether these 2 phenomena are linked or if they are unrelated.
Utilization of ABE to Assign ZDHHCs and Substrates in ECs: ZDHHC21 Is Necessary for Optimal Palmitoylation of PECAM1
The discovery of the large family of ZDHHC PATs has raised the issue of which paralogs are responsible for palmitoylating which substrate proteins. Previously, we demonstrated that ZDHHC3 and ZDHHC21 are expressed in ECs, that both can palmitoylate eNOS when co-expressed in HEK cells, and that siRNA knockdown of ZDHHC21, but not ZDHHC3, in ECs impairs eNOS palmitoylation and activity. 25 We sought to discover new substrates for ZDHHC3 and ZDHHC21 by using siRNA to knockdown both of these PATs ( Figure 3A) . In an initial experiment, ECs were transfected with control siRNA and siRNA targeting both ZDHHC3 and ZDHHC21 and the level of palmitoylation after ABE determined by semiquantitative Western blotting of a group of proteins identified in the EC palmitoylome. As seen in Figure 3B , the knockdown of ZDHHC3 and ZDHHC21 markedly reduced the palmitoylation of PECAM1 (aka CD31) and, to a lesser extent, eNOS, calnexin, and syntaxin-6. The loss of these ZDHHCs did not influence the palmitoylation of MCAM/ MUC18, Yes, G␣ i , R-Ras, total Ras, or caveolin-1, thus demonstrating the specificity of the effect. PECAM1 is a type I transmembrane protein that is expressed in ECs and several circulating blood cells. In the endothelium, it serves several important roles in cell migration, 33, 34 transendothelial migration of leukocytes, 35 flow sensing, 36 and angiogenesis, 37, 38 
Figure 2. The Superoxide dismutase-1 (SOD1) C6S mutant displays decreased nuclear localization and less activity compared with wild-type (WT). A, SOD1
C6S is present at lower levels in the nucleus relative to SOD1 WT. COS cells were transfected with the indicated hydroxylamine (HA)-tagged construct, stained with anti-HA antibody and a fluorescently tagged secondary antibody, and analyzed by confocal microscopy. Representative images are shown. Scale barϭ50 m. B, Quantification of nuclear localization was performed by a blinded independent observer who scored nuclei for the presence or absence of significant HA staining. nϭ3 independent experiments; in total, 66 wild-type (WT) and 72 C6S cells were analyzed. *PϽ0.05. C, Transfection of HA-tagged WT, but not C6S SOD1, led to a reduction in reactive oxygen species, as indicated by fluorescence-activated cell sorting (FACS) of HEK 293T cells loaded with the dye dichlorofluorescin diacetate (DCF). D, Quantification of the mean fluorescence intensity of FACS data from three independent experiments performed in triplicate. *PϽ0.05. E, Western blot shows similar levels of expression of endogenous and transfected SOD1 in lysates from the transfected HEK cells. Hsp90 is shown as a loading control. F, Purification of recombinant SOD1. Heterologously expressed HA-tagged SOD1 WT and C6S mutants were purified using resin conjugated with HA antibody and eluted using HA epitope peptide. SDS-PAGE stained with sypro-ruby confirms a high degree of purity. G, The specific activity of recombinant C6S SOD1 is lower than that of WT SOD1. Activity was measured in triplicate by assessment of inhibition of superoxide production generated by xanthine oxidase/xanthine. Similar results were obtained from two individual protein preparations. among other functions. Palmitoylation of PECAM1 on C595 in platelets was recently described, 39 where it was found to be important for localization of PECAM1 to lipid rafts and for mediating inhibition of stimulated apoptosis.
To determine which PAT was necessary for PECAM1 palmitoylation, each gene was knocked-down alone in ECs, followed by ABE and Western blotting for PECAM1. As seen in Figure 3C , palmitoylation of PECAM1 in ECs was primarily dependent on ZDHHC21, not ZDHHC3. To assess the functional consequences of ZDHHC21-dependent PECAM1 palmitoylation in ECs, we examined whether knockdown of ZDHHC21 affected steady-state levels of endogenous PECAM1. The trafficking, breakdown, and cell surface localization of several other integral membrane proteins have been shown to be affected by palmitoylation. 40 -43 Knockdown of ZDHHC21, but not ZDHHC3, reduced levels of PECAM1 in cell lysates by approximately 50% (Figure 3C ; quantified in Figure 3D ). Similarly, fluorescence-activated cell sorting analysis of cell-surface PECAM1 in nonpermeabilized ECs after knockdown of ZDHHC21 revealed a marked reduction in PECAM1 levels on the cell surface ( Figure 3E ). Thus, ZDHHC21 regulates the levels of PECAM1 in ECs.
Discussion
Palmitoylation has long-been recognized as an important posttranslational modification that can affect protein localization, stability, and function. Using ABE followed by an unbiased proteomic approach, we identified Ͼ150 candidate palmitoyl proteins in ECs. Confidence in the veracity of the identified candidate palmitoylproteins is inherent in the fact that more than half of the identified proteins previously have been reported either by direct biochemical analysis or in other global palmitoylproteomic studies of human cells. In addition, several proteins identified here were confirmed by ABE, followed by Western blotting (Figure 1A, B ) and mutagenesis studies ( Figure 1D ). Thus, our results provide the first global approach in ECs and are an important step forward in the understanding of the role of palmitoylation in this specialized cell type that regulates aspects of cardiovascular disease, cancer, and diabetes.
One interesting novel palmitoylprotein characterized in the present study is SOD1. SOD1 expressed in ECs is of 
. Platelet endothelial cell adhesion molecule-1 (PECAM1) palmitoylation and cell surface expression is dependent on zinc finger DHHC domain-containing protein (ZDHHC) 21 in endothelial cells (ECs). A,
Validation of siRNA-mediated knockdown of ZDHHC3 and ZDHHC21. EA.hy 926 cells were treated with siRNA oligonucleotides targeted against ZDHHC3, ZDHHC21, or nonsilencing (NS) control. Abundance of indicated mRNA was assessed by quantitative polymerase chain reaction (qPCR). nϭ4 independent experiments; *PϽ0.05 compared with NS. B, Screen for substrates of ZDHHC3 and ZDHHC21. EA.hy 926 were treated with either NS control siRNA or siRNA targeted to ZDHHC3 and ZDHHC21. Acyl-biotinyl exchange (ABE) was performed, and the degree of palmitoylation for 10 different proteins in the EC palmitoylproteome was assessed by Western blotting and quantitated by densitometry. PECAM1 palmitoylation was found to be particularly sensitive to knockdown of ZDHHC3 and ZDHHC21. C, PECAM1 palmitoylation is sensitive to ZDHHC21, but not ZHDDC3, knockdown as judged by ABE and Western blotting. Results are typical of three (in the case of the double knockdown) or two independent experiments (in the case of the single knockdowns). Because knockdown of ZDHHC21 can decrease total PECAM1 in the lysates, the input of PECAM1 in this experiment was normalized by using increased amounts of total lysate for samples in which ZDHHC21 was knocked-down as shown by blot of Hsp90. D, Densitometry on Western blots revealed that PECAM1 levels in lysates (normalized to Hsp90) are reduced by approximately 50% after 96 hours of treatment with siRNA targeted to ZDHHC21 but not ZDHHC3. *PϽ0.05 relative to NS control, nϭ3 independent experiments. E, Assessment of PECAM1 cell surface expression by fluorescence-activated cell sorting. Treatment with siRNA targeted to ZDHHC21 led to approximately 60% reduction in mean fluorescence intensity as compared with cells treated with NS control siRNA. Results are typical of 3 independent experiments. particular importance in the pathophysiology of variety of diseases associated with elevated oxidative stress such as atherosclerosis, diabetes, and familial variants of amyotrophic lateral sclerosis. SOD1 has been extensively characterized in biochemical and biophysical experiments, including the determination of several crystal structures. 44 Thus, our detection of SOD1 as a palmitoylprotein was not anticipated. The failure to detect palmitoylation in previous studies may be attributable to many issues such as the presence of reductant in most purification schemes (ie, the thioester would be reduced) and the usage of inappropriate expression and purification strategies combined with insensitive or unsuitable analytic techniques. Interestingly C6 appears to be buried in the crystal structure of the mature form of SOD1. 44 Thus, we suspect that acylation may occur initially in the apoprotein of SOD1, where nuclear magnetic resonance structural data reveal that C6 is solvent-exposed and thus accessible. 45 Significant quantities of apoprotein of SOD1 are thought to exist in the cell at the steady state. 46 Alternatively, it is conceivable that the acyl group is cleaved during maturation of SOD1.
The cysteines of SOD1 have been extensively studied previously by several laboratories in a number of different contexts. The C6F mutation has been found to be among the many mutations that cause familial variants of amyotrophic lateral sclerosis and destabilize the protein. 47 The more conservative C6A mutation was found to slightly enhance rather than inhibit stability. 48 Of note, the introduction of the C6S mutation in the context of familial variant of amyotrophic lateral sclerosis-associated mutations inhibits protein aggregation in experimental studies, 49 possibly by blocking intermolecular disulfide formation involving C6 (and other cysteines); 50 -52 thus, palmitoylation of C6 may serve as an endogenous mechanism to mitigate the reactivity of C6, especially in the aggregation-prone apoprotein associated with the causal familial variant of amyotrophic lateral sclerosis mutations.
Confocal microscopy studies of the SOD1 C6S mutant suggest that nuclear localization is impaired (Figure 2A, B) . Although nuclear localization of SOD1 has been previously recognized, 31 the mechanism by which SOD1 is imported into the nucleus is not known. In general, palmitoylation of nuclear proteins has not been well-described; however, recent data suggest that palmitoylation may be important for the nuclear localization and transcriptional activity of the transcription factor HMGCS2 53 and for the nuclear histone H3. 30 The relationship between the decrease in enzyme activity and the alteration of nuclear localization observed in the SOD1 C6S mutant is not clear and is the subject of further exploration. In addition, it is appreciated that SOD1 can exist in the nucleus in many cells, but the functional importance of SOD1 subcellular localization and its role in EC biology are unknown.
Another salient finding in this study is the identification of relationships between individual ZDHHC paralogs and potential substrates in ECs. To date, most success in identifying such relationships has come from studies designed to define the set of ZDHHC paralogs that can augment palmitoylation of a particular substrate protein. These experiments usually involve cotransfection of a substrate protein together with each of the known ZDHHC proteins in HEK 293 cells, followed by determination of the level of palmitoylation using radioactive palmitate. 54 However, the inverse experiment, ie, determination of all the substrates of a given ZDHHC paralog, is more relevant to understanding the biological role of ZDHHC enzymes and to dissecting the molecular mechanisms of the growing array of in vivo phenotypes that are caused by defects in particular ZDHHC family members.
To this end, we performed ABE after siRNA-mediated knockdown of ZDHHC21 and ZDHHC3, two paralogs found in ECs that palmitoylate eNOS 25 and have identified PE-CAM1 as a palmitoylprotein sensitive to the loss of ZD-HHC21. This knockdown/ABE approach has the advantage of not being subject to artifacts related to overexpression of proteins in a heterologous cell type. Similar approaches have been used in yeast using strains deficient for various PATs, 4 in HeLa cells, where an interaction between CKAP4/p63 and ZDHHC2 was identified, 55 and, most recently, in mouse neural stem cells derived from a mouse with a hypomorphic ZDHHC5 allele. 56 Of note, however, neither the knockdowns nor the overexpression strategies prove a direct enzymesubstrate relationship. Additional studies, perhaps using purified proteins in a reconstitution system, will be required to fully understand the nature of the interaction between a ZDHHC protein and candidate substrate palmitoylprotein.
Several other potential substrates have been reported for ZDHHC21 in addition to PECAM1, including eNOS, 25 Fyn, 19 and Lck. 57 There are known connections among these proteins: eNOS and PECAM1 may interact directly to regulate nitric oxide production in response to flow, 58, 59 and Fyn 60 and Lck 61,62 are reported to phosphorylate PECAM1. These data raise the intriguing possibility that ZDHHC21 may be a global integrator of interactions among related signaling molecules in ECs.
Functionally, we found that knockdown of ZDHHC21 led to reduced levels of PECAM1, especially at the plasma membrane. Palmitoylation of plasma membrane proteins may affect cell surface expression in a variety of ways, including by altering trafficking, increasing internalization, and augmenting degradation. 63 Of note, a recent quantitative proteomic analysis 56 comparing WT and ZDHHC5 hypomorphic neural stem cells revealed that all of the 20 proteins in which palmitoylation was most reduced in the mutant cells also displayed reductions in total protein levels (when data were available). Thus, decreased protein abundance in the setting of reduced palmitoylation, as was observed for PECAM1 ( Figure 3C, D) , may be a common occurrence.
In summary, utilizing ABE technology and mass spectrometry in ECs for the first time, we have discovered several new palmitoylproteins and have begun to assign relationships between ZDHHC paralogs and palmitoylproteins. Specifically, we show that SOD1 is palmitoylated, and that palmitoylation may regulate its nuclear localization and activity. In addition, using siRNA knockdown of two ZDHHC enzymes, we have shown that ZDHHC21 is required for the palmitoylation of the junctional adhesion molecule PECAM1 and regulates its residence and/or stability in the plasma mem-brane. Future studies using ABE technology will further investigate how growth factors or hemodynamic forces alter the composition of the palmitoylomedelineating ZDHHC-substrate pairs as potential targets to regulate EC functions. These experiments will help define the role of S-palmitoylation in EC biology.
